SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 02, 2022
June 2, 2022
 · 
1 min read
Business
Astria Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
May 12, 2022
 · 
10 min read
Genetown
Astria Therapeutics to Present STAR-0215 Data at the 2022 Fc Receptor and IgG Targeted Therapies Conference
April 21, 2022
 · 
5 min read
Deals
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 4, 2022
 · 
1 min read
Business
Astria Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
March 10, 2022
 · 
9 min read
Genetown
Astria Therapeutics to Participate in Upcoming Investor Conferences in March 2022
March 9, 2022
 · 
1 min read
Drug Development
Astria Therapeutics to Present STAR-0215 Data at the 2022 American Academy of Allergy, Asthma and Immunology Annual Meeting
February 18, 2022
 · 
5 min read
Business
Astria Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update
November 10, 2021
 · 
11 min read
Genetown
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
November 9, 2021
 · 
1 min read
Drug Development
Astria Therapeutics Presents New Preclinical Data Showing the Differentiated Profile of STAR-0215, in Development to Treat Hereditary Angioedema
November 5, 2021
 · 
7 min read
Load More